Decibel Cannabis Company (DB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
25 May, 2026Executive summary
Q1 2026 net revenue reached CAD 30 million (USD 29.8 million), up 41% year-over-year, with international sales more than tripling to CAD 9.6 million and adjusted EBITDA doubling to CAD 6.9 million.
Domestic market share climbed 10% sequentially, with Standard Issue brand ranking eighth in vape and tenth in infused pre-rolls.
The company maintained leadership in infused pre-rolls and expanded vape and flower offerings, with new brands and product innovations driving growth.
Major debt refinancing completed and conditional sale of the Creston facility for CAD 2.5 million announced, expected to save CAD 4 million annually.
Exited Q1 with 30% utilization of 60-ton annual flower processing capacity, providing significant room for growth.
Financial highlights
Consolidated net revenues were CAD 30 million, up 41% year-over-year; domestic sales grew 7% to CAD 20 million, and international sales rose over 300% to CAD 9.6 million.
Adjusted EBITDA was CAD 6.9 million, doubling year-over-year; adjusted net income was CAD 3.1 million, up CAD 3.2 million from the prior year.
Free cash flow was negative CAD 14.6 million, impacted by a one-time CAD 13.2 million reduction in payables from February 2026 debt refinancing.
Gross margin reached 51%, up from prior quarters, driven by lower input costs for extracts.
SG&A expenses grew 12% year-over-year, slower than revenue growth; sales and marketing expenses rose 70% but are expected to slow.
Outlook and guidance
2026 guidance reconfirmed: net revenues of CAD 130–135 million (18% growth at midpoint), adjusted EBITDA of CAD 27–31 million (26% growth at midpoint).
Q2 2026 guidance: net revenues of CAD 33–35 million, implying 14% sequential growth at midpoint.
Double-digit international growth expected, with improved German permit timelines and strong demand in Germany and the U.K.
Material free cash flow generation anticipated for the remainder of 2026 as one-time working capital impacts subside.
Management expects high double-digit international sales growth and high single-digit domestic growth through 2026.
Latest events from Decibel Cannabis Company
- Q3 2025 net revenue rose 37% to $32.9M, with strong international growth and revised 2025 guidance.DB
Q3 202528 May 2026 - Strong revenue growth and profitability position the company for accelerated global expansion in 2026.DB
Investor presentation21 May 2026 - Revenue rose 22% to CAD 113 million, fueled by nearly 5x international sales growth.DB
Q4 202522 Apr 2026 - Accelerating international growth and profitability with AgMedica acquisition and strong 2025 outlook.DB
Investor presentation16 Apr 2026 - Strong 2025 results and global expansion position the company for accelerated growth in 2026.DB
Investor presentation16 Apr 2026 - Gross margin rose to 53% as Decibel shifted focus to global markets and improved free cash flow.DB
Q3 202416 Apr 2026 - Strong revenue growth, global expansion, and industry-leading margins drive performance.DB
Investor Presentation21 Nov 2025 - Strong international growth and profitability driven by innovation and regulatory expertise.DB
Planet MicroCap Showcase: TORONTO 202523 Oct 2025 - Record international sales and 35% revenue growth highlight strong Q2 performance.DB
Q2 202512 Sep 2025